188 related articles for article (PubMed ID: 33000942)
1. Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.
Arenaza-Corona A; Couce-Fortúnez MD; de Blas A; Morales-Morales D; Santillan R; Höpfl H; Rodríguez-Blas T; Barba V
Inorg Chem; 2020 Oct; 59(20):15120-15134. PubMed ID: 33000942
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
4. Pd
Amatori S; Ambrosi G; Errico Provenzano A; Fanelli M; Formica M; Fusi V; Giorgi L; Macedi E; Micheloni M; Paoli P; Rossi P
J Inorg Biochem; 2016 Sep; 162():154-161. PubMed ID: 27389827
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(ii) and palladium(ii) homo- and heterobimetallic complexes: synthesis, crystal structures, theoretical calculations and biological studies.
Askari B; Amiri Rudbari H; Micale N; Schirmeister T; Efferth T; Seo EJ; Bruno G; Schwickert K
Dalton Trans; 2019 Nov; 48(42):15869-15887. PubMed ID: 31620752
[TBL] [Abstract][Full Text] [Related]
6. Novel tetranuclear Pd
Oliveira CG; Romero-Canelón I; Coverdale JPC; Maia PIS; Clarkson GJ; Deflon VM; Sadler PJ
Dalton Trans; 2020 Jul; 49(28):9595-9604. PubMed ID: 32602871
[TBL] [Abstract][Full Text] [Related]
7. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
8. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, spectral characterization of novel Pd(II), Pt(II) π-coordination compounds based on N-allylthioureas. Cytotoxic properties and DNA binding ability.
Repich HH; Orysyk VV; Palchykovska LG; Orysyk SI; Zborovskii YL; Vasylchenko OV; Storozhuk OV; Biluk AA; Nikulina VV; Garmanchuk LV; Pekhnyo VI; Vovk MV
J Inorg Biochem; 2017 Mar; 168():98-106. PubMed ID: 28086144
[TBL] [Abstract][Full Text] [Related]
10. Coordination behavior of tetraaza [N₄] ligand towards Co(II), Ni(II), Cu(II), Cu(I) and Pd(II) complexes: synthesis, spectroscopic characterization and anticancer activity.
El-Boraey HA
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():255-62. PubMed ID: 22765944
[TBL] [Abstract][Full Text] [Related]
11. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
13. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
Matesanz AI; Leitao I; Souza P
J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
[TBL] [Abstract][Full Text] [Related]
14. Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.
Almotairy ARZ; Montagner D; Morrison L; Devereux M; Howe O; Erxleben A
J Inorg Biochem; 2020 Sep; 210():111125. PubMed ID: 32521289
[TBL] [Abstract][Full Text] [Related]
15. Designing binuclear transition metal complexes: a new example of the versatility of N,N'-bis(2-aminobenzyl)-4,13-diaza-18-crown-6.
Vaiana L; Platas-Iglesias C; Esteban-Gómez D; Avecilla F; Clemente-Juan JM; Real JA; de Blas A; Rodríguez-Blas T
Dalton Trans; 2005 Jun; (11):2031-7. PubMed ID: 15909055
[TBL] [Abstract][Full Text] [Related]
16. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
[TBL] [Abstract][Full Text] [Related]
18. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores.
Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L
J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184
[TBL] [Abstract][Full Text] [Related]
19. Pt(II) and Pd(II) derivatives of ter-butylsarcosinedithiocarbamate. Synthesis, chemical and biological characterization and in vitro nephrotoxicity.
Fregona D; Giovagnini L; Ronconi L; Marzano C; Trevisan A; Sitran S; Biondi B; Bordin F
J Inorg Biochem; 2003 Jan; 93(3-4):181-9. PubMed ID: 12576280
[TBL] [Abstract][Full Text] [Related]
20. New palladium and platinum complexes with bioactive 3,5-diacetyl-1,2,4-triazol bis(4-cyclohexyl thiosemicarbazone) ligand: chemistry, antiproliferative activity and preliminary toxicity studies.
Matesanz AI; Perles J; Souza P
Dalton Trans; 2012 Oct; 41(40):12538-47. PubMed ID: 22955178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
